Versor Investments LP Takes $2.09 Million Position in Cardinal Health, Inc. $CAH

Versor Investments LP purchased a new position in Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 13,313 shares of the company’s stock, valued at approximately $2,090,000. Cardinal Health makes up about 0.4% of Versor Investments LP’s portfolio, making the stock its 26th biggest holding.

Other large investors also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. raised its position in shares of Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC increased its stake in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. American Capital Advisory LLC increased its stake in Cardinal Health by 5,200.0% during the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock worth $33,000 after buying an additional 208 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC raised its holdings in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $225.88 on Tuesday. The stock has a 50 day moving average of $207.28 and a 200 day moving average of $180.77. The firm has a market capitalization of $53.15 billion, a price-to-earnings ratio of 32.50, a PEG ratio of 1.48 and a beta of 0.64. Cardinal Health, Inc. has a fifty-two week low of $120.72 and a fifty-two week high of $230.81.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, February 5th. The company reported $2.63 EPS for the quarter, beating the consensus estimate of $2.31 by $0.32. The business had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.93 EPS. Analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CAH shares. TD Cowen reaffirmed a “buy” rating on shares of Cardinal Health in a research note on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Morgan Stanley set a $255.00 target price on shares of Cardinal Health in a research report on Friday. Argus raised their price target on shares of Cardinal Health from $211.00 to $232.00 and gave the stock a “buy” rating in a research note on Friday, January 23rd. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Fifteen research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $241.27.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.